Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Biomolecular Characterization Device

RedShift BioAnalytics Inc.Request Info
Facebook Twitter LinkedIn Email
BURLINGTON, Mass., May 17, 2022 — Biomolecular Characterization DeviceThe Apollo biomolecular characterization device from RedShift BioAnalytics Inc. uses microfluidic modulation spectroscopy (MMS) technology to provide sensitive, precise measurements of biomolecule structures.

Users are able to compare higher-order structure and similarity profiles for confidence in structural similarity and activity to inform discovery, screening, formulation, and quality control in biopharmaceutical drug development. The device provides accurate and reproducible measurements with a broad concentration range from 0.1 mg/ml to >200 mg/ml, allowing measurement in native conditions.
May 2022
* First Name:
* Last Name:
* Email Address:
* Company:
* Country:

When you click "Send Request", we will record and send your personal contact information to RedShift BioAnalytics Inc. by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.

Register or login to auto-populate this form:
Login Register
* Required

ProductsApollobiomolecular characterization deviceRedshift BioanalyticsTest & MeasurementspectroscopyBiophotonicsR&DmedicinemedicalAmericas

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.